Furthermore, the mRNA expression levels of Th17-related factors (IL-17 and IL-23p19) in tumor tissues and the serum concentrations of IL-17 and IL-23 cytokines were significantly increased in patients with advanced GC. The gene discussed is IL17A; the disease is gastric cancer.